Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

Isomorphic Labs, the Alphabet Inc.-owned company that uses artificial intelligence to discover drugs, has raised $600 million ...

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

We recently published a list of Jim Cramer is Discussing These 10 Stocks Ahead of Q1 Earnings Season. In this article, we are ...

Alphabet’s Gemini 2.5 Pro sets new AI benchmarks, powered by DeepMind and custom TPUs. Learn why GOOG stock offers long-term ...

Alphabet's diverse, high-margin growth engines like AI, Cloud & YouTube drive strong revenue growth. Click here to read my ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

While two AI leaders with undeniable competitive moats are historically cheap, another Wall Street darling is staring down a ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

WestPark Capital analyst Curtis Shauger initiated coverage on Alphabet (NASDAQ:GOOG) on Tuesday with a Buy rating and a price ...